Table 1 Demographic data, spherical equivalent, number of injections and the size of CNV
From: Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
|  | Total number of examined eyes n = 20 | Age of the studied cases | Test of significance | |
|---|---|---|---|---|
< 40 years n = 8 | ≥ 40 years n = 12 | |||
Age (years) | ||||
 Range | 31–63 | 31–39 | 40–63 | P = 0.001* |
Gender n(%) | ||||
 Male | 8 (40%) | 3 (37.5%) | 5 (41.7%) | χ2 = 0.035 |
 Female | 12 (60%) | 5 (62.5%) | 7 (58.3%) | P = 0.852 |
Spherical equivalent | ||||
 Mean ± S. D | −7.05 ± 0.52 | −6.78 ± 0.36 | −7.23 ± 0.55 | t = 2.03 |
 Range | (−8)-(−6.25) | (−7.25)–(− 6.25) | (−8)–(− 6.25) | P = 0.058 |
No of injections | ||||
 Mean ± S. D | 2.30 ± 0.92 | 2.00 ± 0.76 | 2.50 ± 1.00 | t = 1.198 |
 Range | (1–4) | (1–3) | (1–4) | p = 0.246 |
Size of CNV by disc diameter | ||||
 Mean ± S. D | 0.65 ± 0.42 | 0.59 ± 0.37 | 0.88 ± 0.55 | t = 1.30 p = 0.209 |